Gene Therapy and CRISPR
Cross-source consensus on Gene Therapy and CRISPR from 1 sources and 3 claims.
1 sources · 3 claims
Uses
Comparisons
Evidence quality
Highlighted claims
- Gene therapy and gene editing are used as a comparison for how risky unfamiliar technologies may first become acceptable. — Neuralink and Brain-AI Integration
- CRISPR and related gene-editing approaches were especially relevant to rare-disease patients who lacked viable alternatives. — Neuralink and Brain-AI Integration
- Severe conditions with no effective alternatives can make experimental technology seem reasonable or even ideal. — Neuralink and Brain-AI Integration